wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38640422-A6E3DAF5-15C8-4872-9E4B-40CE605C83E3
Q38640422-A6E3DAF5-15C8-4872-9E4B-40CE605C83E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38640422-A6E3DAF5-15C8-4872-9E4B-40CE605C83E3
Chronic myeloid leukemia: Second-line drugs of choice.
P2860
Q38640422-A6E3DAF5-15C8-4872-9E4B-40CE605C83E3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38640422-A6E3DAF5-15C8-4872-9E4B-40CE605C83E3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
67eee066dda75611449c8b3e95463dd9ba1f0164
P2860
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.